Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Breast Carcinoma”

753 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 753 results

Large-scale testing (Phase 3)UnknownNCT00944424
What this trial is testing

Phase III Trial of High Dose vs. Standard Dose Vit D2 With Docetaxel in Met Breast ca

Who this might be right for
Breast Cancer
King Faisal Specialist Hospital & Research Center 260
Large-scale testing (Phase 3)Looking for participantsNCT03201861
What this trial is testing

Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women

Who this might be right for
Tubular Breast CancerMucinous Breast CancerInvasive Duct Carcinoma of Breast
RenJi Hospital 762
Early research (Phase 1)Ended earlyNCT04099277
What this trial is testing

LY3435151 in Participants With Solid Tumors

Who this might be right for
Solid TumorTriple-negative Breast CancerGastric Adenocarcinoma+6 more
Eli Lilly and Company 2
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Not applicableUnknownNCT05142202
What this trial is testing

High Five (HiFi) Accelerated Partial Breast Irradiation Study

Who this might be right for
Breast Cancer
The Greater Poland Cancer Centre 147
Early research (Phase 1)Study completedNCT00821054
What this trial is testing

Examine the Effects of Low and High-fat Meals on Orally Administered Lapatinib in Metastatic ErbB2 Positive Breast Cancer Patients

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT01419730
What this trial is testing

Vitamin D and Physical Activity on Bone Health

Who this might be right for
Bone Metabolism BiomarkersBone Mineral DensityPhysical Fitness
University of Rochester 191
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Large-scale testing (Phase 3)UnknownNCT05673629
What this trial is testing

Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer

Who this might be right for
Breast Cancer
Beijing Biostar Pharmaceuticals Co., Ltd. 552
Not applicableStudy completedNCT00032201
What this trial is testing

Cell Lines From High-Risk Breast Tissue

Who this might be right for
Healthy
National Cancer Institute (NCI) 43
Not applicableStudy completedNCT02178475
What this trial is testing

Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy

Who this might be right for
Chemotherapy-induced Febrile Neutropenia
Amgen 943
Not applicableUnknownNCT03617341
What this trial is testing

Brain Monitoring for High Risk of Brain Metastases in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer With HER2 PositiveTriple Negative Breast Cancer
Yonsei University 200
Testing effectiveness (Phase 2)Ended earlyNCT04149522
What this trial is testing

Evaluation of Mepitel Film® in Preventing Epidermitis in Patients Receiving Radiation Therapy for Breast Cancer

Who this might be right for
Breast CancerRadiotherapy; Adverse Effect, Dermatitis or EczemaRadiotherapy Side Effect+3 more
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) 40
Not applicableStudy completedNCT02770586
What this trial is testing

Comparison of Positron Emission Mammography and Contrast-enhanced Breast MRI

Who this might be right for
Breast Cancer
Mayo Clinic 50
Testing effectiveness (Phase 2)Looking for participantsNCT07017673
What this trial is testing

Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer

Who this might be right for
TNBCTNBC - Triple-Negative Breast CancerEarly Stage Triple-Negative Breast Carcinoma
Cedars-Sinai Medical Center 34
Testing effectiveness (Phase 2)Looking for participantsNCT05332561
What this trial is testing

Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE)

Who this might be right for
Early-stage Breast Cancer
German Cancer Research Center 240
Not applicableEnded earlyNCT01938651
What this trial is testing

Ultra High Field MRI and MRS Techniques in Diagnosing Breast Cancer

Who this might be right for
Breast Cancer
Vanderbilt-Ingram Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT00847171
What this trial is testing

Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Not applicableLooking for participantsNCT05658172
What this trial is testing

Standard Surveillance vs. Intensive Surveillance in Early Breast Cancer

Who this might be right for
Breast Cancer
Prof. Wolfgang Janni 3,500
Large-scale testing (Phase 3)Active Not RecruitingNCT04595565
What this trial is testing

Sacituzumab Govitecan in Primary HER2-negative Breast Cancer

Who this might be right for
HER2-negative Breast CancerTriple Negative Breast Cancer
GBG Forschungs GmbH 1,332
Load More Results